©2011 Baishideng Publishing Group Co.
World J Gastrointest Pharmacol Ther. Aug 6, 2011; 2(4): 27-35
Published online Aug 6, 2011. doi: 10.4292/wjgpt.v2.i4.27
Published online Aug 6, 2011. doi: 10.4292/wjgpt.v2.i4.27
Table 2 Dosage regimens for agents used for stress ulcer prophylaxis
| Medication | Adult raNGe |
| Cimetidine | 300 mg qid po, NG, or iv or 50 mg/h by continuous iv infusion |
| Famotidine | 20 mg bid po, NG, or iv or 1.7 mg/h by continuous iv infusion |
| Ranitidine | 150 mg bid po or NG, 50 mg every 6-8 h iv, or 6.25 mg/h by continuous iv infusion |
| Nizatidine | 150 mg bid po or NG |
| Antacids | 30-60 mL po or NG every 1-2 h |
| Sucralfate | 1 g qid po or NG |
| Omeprazole | 40 mg LD then 20-40 mg daily po, NG or iv |
| Lansoprazole | 30 mg daily po, NG or iv |
| Esomeprazole | 20-40 mg daily po, NG or iv |
| Rabeprazole | 20 mg daily po or NG |
| Pantoprazole | 40 mg daily po or NG or iv |
- Citation: Zeitoun A, Zeineddine M, Dimassi H. Stress ulcer prophylaxis guidelines: Are they being implemented in Lebanese health care centers? World J Gastrointest Pharmacol Ther 2011; 2(4): 27-35
- URL: https://www.wjgnet.com/2150-5349/full/v2/i4/27.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v2.i4.27